85 related articles for article (PubMed ID: 7229370)
1. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
Ostrand-Rosenberg S; Cohan VL
J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
[TBL] [Abstract][Full Text] [Related]
2. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
Ostrand-Rosenberg S; Cohn AL; Sandoz JW
J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
[TBL] [Abstract][Full Text] [Related]
3. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
Ostrand-Rosenberg S; Cohn A
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
Bartlett PF; Fenderson BA; Edidin M
J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
[TBL] [Abstract][Full Text] [Related]
5. Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.
Ostrand-Rosenberg S; Clements V
Immunogenetics; 1987; 26(1-2):1-5. PubMed ID: 3301646
[TBL] [Abstract][Full Text] [Related]
6. Lack of histocompatibility antigens on a murine ovarian teratocarcinoma.
Vanhaelen CP; Fisher RI; Appella E; Ramanathan L
Cancer Res; 1981 Aug; 41(8):3186-91. PubMed ID: 7018676
[TBL] [Abstract][Full Text] [Related]
7. Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo.
Isa AM
Transplantation; 1976 Mar; 21(3):196-8. PubMed ID: 781924
[TBL] [Abstract][Full Text] [Related]
8. Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor.
Ostrand-Rosenberg S; Schwartzman ML; Hecht TT; Marr L
Cell Immunol; 1986 May; 99(2):453-60. PubMed ID: 3093106
[TBL] [Abstract][Full Text] [Related]
9. Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.
Ostrand-Rosenberg S; Cole GA; Nishimura MI; Clements VK
Cell Immunol; 1990 Jun; 128(1):152-64. PubMed ID: 2344619
[TBL] [Abstract][Full Text] [Related]
10. Differential H-2 antigen expression in teratocarcinoma-fibroblast hybrids.
Sionov RV; Gallily R
Exp Clin Immunogenet; 1995; 12(4):238-44. PubMed ID: 8919356
[TBL] [Abstract][Full Text] [Related]
11. Antisperm antibodies in mouse vasectomy sera react with embryonal teratocarcinoma.
Anderson DJ; Adams PH; Hamilton MS; Alexander NJ
J Immunol; 1983 Dec; 131(6):2908-12. PubMed ID: 6644023
[TBL] [Abstract][Full Text] [Related]
12. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
[TBL] [Abstract][Full Text] [Related]
14. 402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cells.
Ostrand-Rosenberg S; Clements V; Marr L
Cell Immunol; 1986 Apr; 98(2):257-65. PubMed ID: 3093094
[TBL] [Abstract][Full Text] [Related]
15. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
Chen Z; Rosten SI; Lord EM; Gaspari AA
Reg Immunol; 1993; 5(5):285-92. PubMed ID: 8148238
[TBL] [Abstract][Full Text] [Related]
16. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
17. H-2 expression on a teratocarcinoma-derived cell line, TerC.
Searls DB; Edidin M
J Natl Cancer Inst; 1982 Dec; 69(6):1311-5. PubMed ID: 6958907
[TBL] [Abstract][Full Text] [Related]
18. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
[TBL] [Abstract][Full Text] [Related]
20. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
